Ovarian Cancer News

News

After nearly a decade of campaigning, Ovarian Cancer Action reviews the findings in the government-funded National Ovarian Cancer Audit. This milestone follows their groundbreaking feasibility pilot, which highlighted urgent inequalities in diagnosis and treatment. Learn how supporter action and advocacy helped make this audit a reality.

News

Our Research Grants and Impacts Manager, talks us through a patient involvement workshop held with Professor Ahmed whilst he was developing his research on ovarian cancer vaccines and why the patient voice is crucial to pushing key research forward.

News

Groundbreaking research funded by Ovarian Cancer Action has received a major boost from Cancer Research UK to develop the world’s first vaccine to prevent ovarian cancer. Discover how this innovative project could save lives.

News

Discover how Ovarian Cancer Action’s 2019 HHMT Forum helped spark groundbreaking ovarian cancer immunotherapy research, leading to a promising vaccine now funded by Cancer Research UK. See how global collaboration is driving progress.

News

Researchers have been exploring whether testing women with symptoms that might be linked to ovarian cancer is a good way to find aggressive types of the disease early. Find out more about symptoms-triggered testing and why screening research is still important for ovarian cancer survival rates.

News

Ovarian Cancer Action joins 21 other funders of cancer research wishing to maximise the value and benefits of cancer research for patients and the public.

News

The brand new NICE guideline ‘Ovarian cancer: identifying and managing familial and genetic risk’ has been published today. We break down what it means.

News

We outline what the programme is and answer some common questions.

News

At Ovarian Cancer Action, we want all women to survive ovarian cancer. We’re determined to make sure every woman gets the treatment they need when they need it. For World Cancer Day 2024, we went to the Houses of Parliament, alongside 20 cancer charities, to call on the Government and opposition parties to drastically reduce waiting times for cancer patients.

News

The National Institute for Health and Care Excellence have approved the combination of olaparib with bevacizumab for the maintenance treatment of high-grade epithelial ovarian cancer, fallopian tube cancer or primary peritoneal cancer.

News

We explore why women with a high inherited risk of cancer might opt to have their ovaries removed at the same time as having a caesarean section.

News

Our Grants and Impacts Manager, Faye, travelled to Boston to hear from the global voices in ovarian cancer research at a conference run by the American Association for Cancer Research. Faye talks through her time at the conference, the key speakers and meeting other charities with a united purpose.

News

The consultation period for the guidelines ‘Ovarian cancer: identifying and managing familial and genetic risk’ is open and we want you – our community – to have your voice heard.

News

The Isle of Man Anti-Cancer Association brought cancer awareness information to the local communities across the Island. We talk about how the charity started and why ovarian cancer awareness is so important to the people of the Isle of Man.

News

Professor Iain McNeish and his team at the Ovarian Cancer Action Research Centre have made two new discoveries that could lead to more women surviving ovarian cancer.

News

Our Head of Research and Policy, Marie-Claire Platt, travelled to Aberdeen for the British Gynaecological Cancer Society's annual meeting, to share the first results of our IMPROVE UK programme.

News

Today the results of the first pilots in the IMPROVE UK programme have been presented at the British Gynaecological Cancer Society annual conference in Aberdeen, Scotland.

News

Our researchers have discovered that relying on a single biopsy from a single location may not adequately represent the entire spectrum of a patient's tumour profile, potentially leading to suboptimal treatment decisions.

News

We all have BRCA genes. And men are just as likely as women to inherit a fault in those genes and pass them on to any children they have. So what do men and their families need to know when it comes to BRCA?

News

The National Institute for Health and Care Excellence has extended access to olaparib so that all patients with a BRCA gene mutation can now benefit from the drug